http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3819293-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dba7fe6f9247464c040c5d0e34114c57
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b8688d2b2c8ccca868ca9728c7dd29b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74f3639d9c105bf308f58060f46b8739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_373fd326a6faa8b22f032366489c2b75
publicationDate 2021-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3819293-A4
titleOfInvention ANTAGONIST SALT AND CRYSTALLINE FORM OF ANGIOTENSIN II RECEPTOR 2, AND THEIR PREPARATION PROCESS
priorityDate 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011088504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3620454-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001

Total number of triples: 23.